Grand Rounds | 2022-2023

A THI EDUCATION TRADITION

Commitment to Learning & Professional Fellowship

Since its founding in 1962, THI has remained dedicated to improving the standard of care and advancing knowledge through cardiovascular education and research.  Texas Heart Institute Grand Rounds is an esteemed tradition that attracts leading experts from around the world each year. Texas Heart Institute Grand Rounds is hosted in the Denton A. Cooley Auditorium at 6770 Bertner Avenue in Houston, TX.

Series attendees include cardiology fellows and faculty, members of the Departments of Internal Medicine and Cardiovascular Surgery, as well as visitors from other clinical and teaching institutions in the Texas Medical Center. Grand Rounds is livebroadcasted for online viewing on any desktop computer or mobile device.  

A Continuing Medical Education Activity

Accreditation and Credit Designation

Texas Heart Institute Cardiology Grand Rounds provides a weekly opportunity to learn from leading medical and surgical experts, sharing the latest advancements and innovations in the diagnosis, treatment, and prevention of cardiovascular disease. Located in the Denton A. Cooley Auditorium, THI offers CME credits for participation in Grand Rounds. Attendees can also log in from any computer, phone, or tablet to participate in the Live Webcast.


Texas Heart Institute is accredited by the Accreditation Council or Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Texas Heart Institute designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Texas Heart Institute
Houston, TX

Baylor College of Medicine
Texas Heart Institute
Houston, TX

Lewis Katz School of Medicine
Temple University
Philadelphia, PA

Indiana University School of Medicine
Indianapolis, IN

Duke University School of Medicine
Durham, NC

University of Arizona College of Medicine
Tucson, AZ

Morton J. Kern, MD, MSCAI, FAHA, FACC

University of California, Irvine Medical Center
Orange, CA

National Heart Centre Singapore

University of California, San Francisco
San Francisco, CA

Baptist Health Medical Group
Louisville, KY

University of Texas Southwestern Medical Center
Dallas, TX

Advanced Cardiovascular & Vascular Centers
Grand Rapids, MI

Baylor College of Medicine
Houston, TX

Monash University
Melbourne, Australia

Icahn School of Medicine at Mount Sinai
New York, NY

University of Texas Southwestern Medical Center
Dallas, TX

Baylor College of Medicine
Texas Heart Institute
Baylor Saint Luke's Medical Center
Houston, TX

Duke University School of Medicine
Durham, NC

Texas Heart Institute
Houston, TX

Northwestern University Feinberg School of Medicine
Evanston, IL

Massachusetts General Hospital
Boston, MA

Baylor College of Medicine
Houston, TX

University of South Florida Heart Institute
Tampa, FL

September 16 | John M. Mandrola, MD | Putting Dogmas of Cardiology to the Test

Putting Dogmas of Cardiology to the Test

John M. Mandrola, MD
Cardiology & Electrophysiology
Baptist Health

Overview:

While the field of cardiology has been exemplary in the generation of evidence, much of what we now accept as therapeutic fashion comes with weak evidentiary support. My goal is to use historical lessons as a means to render learners less susceptible to dogma and medical reversals.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Use seminal trials to guide current critical appraisal
  • Resist the urge to accept practices with weak evidentiary support
  • Use critical appraisal skills to reset prior beliefs about what does and does not benefit patients

Disclosures:

John Mandrola, MD has nothing to disclose relevant to the content of his presentation

The Planning Committee has nothing to disclose relevant to this program.

The THI CME Staff has nothing to disclose relevant to this program.

The Program Reviewers has nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Educational Grants

This continuing medical education activity has been supported in part by educational grants from the following company:  None to Date

September 23 | Paolo E. Angelini, MD | Takotsubo Cardiomyopathy: Can We Finally Clarify its Cause and Pathophysiology?

Takotsubo Cardiomyopathy: Can We Finally Clarify its Cause and Pathophysiology?

Paolo E. Angelini, MD
Interventional Cardiology
Texas Heart Institute

 

Overview:

Takotsubo cardiomyopathy (TTC) is a persistently confusing condition especially affecting women.

Its causes and most effective treatment are still unclear.  We have developed at Texas heart institute a novel theory based on endothelial dysfunction and coronary spasm.  We have substantial objective evidence now to claim that TTC can finally be reproduced in the Cath lab by acetylcholine testing of endothelial dysfunction and that intracoronary nitroglycerine can reliably abort the presentation.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Discuss the condition to establish the individual patient liability to Takotsubo is endothelial dysfunction. Acetylcholine testing can reproduce this entity during heart catheterization. Catecholamine surge can be a non-essential precipitating cause in predisposed patients.
  • Discuss Nitroglycerine that can apparently abort Takotsubo if given early in its onset. Long term Calcium antagonists can apparently be successful in preventing relapsing.

Disclosures:

Paolo E. Angelini, MD has nothing to disclose relevant to this program.

The Planning Committee has nothing to disclose relevant to this program.

The THI CME Staff has nothing to disclose relevant to this program.

The Program Reviewers has nothing to disclose relevant to this program.

Accreditation

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Educational Grants

This continuing medical education activity has been supported in part by educational grants from the following company:  None to Date

September 30 | Ourania Preventza, MD, MBA, FACS | Current Management of Acute Type B Aortic Dissection


Current Management of Acute Type B Aortic Dissection

Ourania Preventza, MD
Cardiothoracic Surgery
Baylor St Luke’s Medical Center

 

Overview:

We will discuss current management of acute Type B aortic dissection: Pros and cons of medical and surgical management

Objectives:

At the conclusion of the activity a participant should be able to:

  • Review the latest advances and management of acute Type B aortic dissection
  • Discuss the pros and cons of medical versus surgical treatment

Disclosures:

Ourania Preventza, MD is a consultant for W. L. Gore and Terumo.

The Planning Committee has nothing to disclose relevant to this program.

The THI CME Staff has nothing to disclose relevant to this program.

The Program Reviewers has nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Educational Grants

This continuing medical education activity has been supported in part by educational grants from the following company:  None to Date

October 7 | Subhasis Chatterjee, MD, FACS |

October 14 | Salim Virani, MD, PhD, FACC, FAHA, FASPC |

October 21 | Anthony B. Firulli, PhD |

October 28 | Ambarish Pandey, MD, MS, FAHA | Leveraging Novel Risk Prediction Approaches to Avoid the Sugary Slope of Diabetes to Heart Failure

THURSDAY November 3 | Carolyn Lam, MBBS, PHD, FRCP, FAMS, FACC, FESC |

November 11 | Ajith Nair, MD, FACC, FAHA | Innovations in Heart Failure

November 18 | Robert H. Lustig, MD, MSL | Cariology and Cardiology: Chronic Disease and the Toxic Food Supply

December 2 | Howard A. Rockman, MD

December 9 | Jagmeet Singh, MD, PhD

January 13 | Jihad Mustapha, MD, FACC, FSCAI | Below the Knee Intervention & Critical Limb Ischemia Outcomes (Virtual)

January 20 | Da-Zhi Wang, PhD, FAHA |

January 27 | John Elrod, PhD |

February 3 | Darren K. McGuire, MD, MHSc |

February 10 | Sanjiv J. Shah, MD

February 23 | Morton J. Kern, MD, MSCAI, FAHA, FACC | BCM Lectureship

March 3 | Steve Nicholls, MD |

March 10 | Henk L. Granzier, PhD |

March 17 | TBA

March 24 | Jeffrey W. Olin, DO, FACC, FAHA, MSVM | Fibromuscular Dysplasia: The Rare Disease that Isn’t

March 31 | TBA

April 7 | TBA

April 21 | TBA

April 28 | TBA

May 5 | TBA

May 12 | TBA

May 19 | TBA

May 26 | Joseph Rogers, MD |